New cholesterol drug HRS-1301 passes early safety check in 82 healthy people
NCT ID NCT06857253
First seen Jan 03, 2026 · Last updated May 13, 2026 · Updated 18 times
Summary
This early-stage study tested a new drug called HRS-1301 in 82 healthy adults to see if it is safe and how the body processes it. The goal is to eventually use it to control high cholesterol, which is a risk factor for heart disease. Participants took single or multiple doses, and researchers monitored for side effects and drug levels in blood and urine.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.